362 related articles for article (PubMed ID: 25566237)
1. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
Front Microbiol; 2014; 5():728. PubMed ID: 25566237
[TBL] [Abstract][Full Text] [Related]
2. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
4. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.
Ambrosio MR; Navari M; Di Lisio L; Leon EA; Onnis A; Gazaneo S; Mundo L; Ulivieri C; Gomez G; Lazzi S; Piris MA; Leoncini L; De Falco G
Infect Agent Cancer; 2014; 9():12. PubMed ID: 24731550
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
7. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.
Navari M; Etebari M; De Falco G; Ambrosio MR; Gibellini D; Leoncini L; Piccaluga PP
Front Microbiol; 2015; 6():556. PubMed ID: 26113842
[TBL] [Abstract][Full Text] [Related]
8. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.
Crombie JL; LaCasce AS
Front Oncol; 2019; 9():109. PubMed ID: 30899698
[TBL] [Abstract][Full Text] [Related]
9. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
[TBL] [Abstract][Full Text] [Related]
10. EBV-Encoded Latent Genes.
Kanda T
Adv Exp Med Biol; 2018; 1045():377-394. PubMed ID: 29896676
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
12. Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.
Hui KF; Yiu SPT; Tam KP; Chiang AKS
Front Oncol; 2019; 9():81. PubMed ID: 30873380
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-associated lymphomas.
Shannon-Lowe C; Rickinson AB; Bell AI
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893938
[TBL] [Abstract][Full Text] [Related]
14. Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact.
Ferla V; Rossi FG; Goldaniga MC; Baldini L
Front Oncol; 2020; 10():506. PubMed ID: 32457824
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
17. Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.
Gulley ML; Sargeant KP; Grider DJ; Eagan PA; Davey DD; Damm DD; Robinson RA; Vandersteen DP; McGuff HS; Banks PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):425-31. PubMed ID: 8521106
[TBL] [Abstract][Full Text] [Related]
18. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients.
Niedobitek G; Mutimer DJ; Williams A; Whitehead L; Wilson P; Rooney N; Young LS; Hübscher SG
Int J Cancer; 1997 Nov; 73(4):514-20. PubMed ID: 9389565
[TBL] [Abstract][Full Text] [Related]
20. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
